TrialEBioMedicine2020

Hematopoietic stem-cell senescence and myocardial repair - Coronary artery disease genotype/phenotype analysis of post-MI myocardial regeneration response induced by CABG/CD133+ bone marrow hematopoietic stem cell treatment in RCT PERFECT Phase 3.

Markus Wolfien et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.